Antineoplastic Combined Chemotherapy Protocols
Showing 1 - 25 of >10,000
Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])
Not yet recruiting
- Neoplasms
- +2 more
- Nivolumab Injection [Opdivo]
- (no location specified)
Jul 19, 2023
Oral Mucositis, Chemotherapeutic Toxicity, Childhood Cancer Trial in Porto Alegre (Diode Semiconductor, Duo, Gemini laser)
Recruiting
- Oral Mucositis
- +2 more
- Diode Semiconductor, Duo
- Gemini laser
-
Porto Alegre, Rio Grande Do Sul, BrazilFederal University of Rio Grande do Sul
Mar 30, 2023
Pancreatic Cancer Non-resectable, Chemo Effect, Ultrasound Therapy Trial in Seoul (ALPIUS 900, an ultrasound-guided high
Recruiting
- Pancreatic Cancer Non-resectable
- +2 more
- ALPIUS 900, an ultrasound-guided high intensity focused ultrasound system
- FOLFIRINOX regimen
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 20, 2022
Chemo-induced Nausea and Vomiting (CINV) Trial in Shanghai (Granisetron Transdermal Delivery System)
Recruiting
- Chemotherapy-induced Nausea and Vomiting (CINV)
- Granisetron Transdermal Delivery System
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 19, 2022
Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with
Recruiting
- Lung Squamous Cell Carcinoma
- To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
-
Yancheng, Jiangsu, ChinaYancheng Clinical College of Xuzhou Medical University
Mar 21, 2023
Oropharyngeal Cancer Trial in Shanghai (Toxicities reduced treatment, Conventional treatment)
Recruiting
- Oropharyngeal Cancer
- Toxicities reduced treatment
- Conventional treatment
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 26, 2023
Drug Induced Neuropathy in Children With ALL
Recruiting
- Acute Lymphocytic Leukemia
-
Trieste, Friuli Venezia Giulia, ItalyIRCCS materno infantile Burlo Garofolo
Mar 31, 2023
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Not yet recruiting
- Non-small Cell Lung Cancer
- Immunotherapy
- +2 more
-
Fuzhou, Fujian, China900TH Hospital of Joint Logisti'cs Support Force
Aug 2, 2022
CIPN and it's Impact on Quality of Life in Patients Receiving
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Apr 24, 2023
Triple Negative Breast Cancer Trial (Ociperlimab, Tislelizumab, Paclitaxel)
Not yet recruiting
- Triple Negative Breast Cancer
- Ociperlimab
- +7 more
- (no location specified)
Mar 30, 2023
Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)
Recruiting
- Locally Advanced Breast Cancer
- Chemotherapy Effect
- inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
-
Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Feb 28, 2023
Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)
Not yet recruiting
- Hypopharyngeal Cancer
- Cisplatin/Nedaplatin, albumin paclitaxel
- (no location specified)
May 5, 2023
Breast Cancer After Ovarian Cancer During and/or After Therapy:
Recruiting
- BRCA-Associated Breast Carcinoma
- Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023
Endometrial Cancer, Serous Adenocarcinoma, Uterine Tumor Trial (Niraparib oral capsule)
Not yet recruiting
- Endometrial Cancer
- +2 more
- Niraparib oral capsule
- (no location specified)
Oct 31, 2022
Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)
Recruiting
- Larynx Cancer
- Hypopharyngeal Cancer
- Surgery
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 9, 2023
Cognitive Impairment in Young Patients With Cancer Prospectively
Recruiting
- Chemotherapy-Related Cognitive Impairment
- +9 more
-
Copenhagen, DenmarkRigshospitalet
Apr 24, 2023
Lymphoma, Non-Hodgkin, HIV Trial in New Orleans (Methotrexate, Leucovorin calcium, Zidovudine)
Terminated
- Lymphoma, Non-Hodgkin
- HIV Infections
- Methotrexate
- +3 more
-
New Orleans, LouisianaTulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU
Oct 27, 2021
Tafasitamab in Combination With Lenalidomide in Patients withR/R
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Tafasitamab Injection
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
May 31, 2023
Solid Tumor Trial in China (TQB2450 injection, AL2846 capsule, Pemetrexed disodium for injection)
Active, not recruiting
- Solid Tumor
- TQB2450 injection
- +3 more
-
Beijing, Beijing, China
- +11 more
Oct 31, 2023
Breast Cancer Trial in Toronto (Combined Exercise + Behavioural Counselling, Active Control)
Not yet recruiting
- Breast Cancer
- Combined Exercise + Behavioural Counselling
- Active Control
-
Toronto, Ontario, CanadaFaculty of Kinesiology and Physical Education, University of Tor
Jan 19, 2023
Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)
Unknown status
- Sarcoma
- +16 more
- Sequential chemotherapy - 3 courses of AI
- Hypofractionated radiotherapy
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021
Prostate Cancer Trial in France (Docetaxel every 3 weeks + Prednisone, Docetaxel weekly+ Prednisone)
Completed
- Prostate Cancer
- Docetaxel every 3 weeks + Prednisone
- Docetaxel weekly+ Prednisone
-
Albi, France
- +30 more
Jun 7, 2021
Gastric Cancer, Peritoneal Metastases, Chemo Effect Trial in London (Doxorubicin and Cisplatin)
Not yet recruiting
- Gastric Cancer
- +2 more
- Doxorubicin and Cisplatin
-
London, United KingdomImperial College London, Hammersmith Hospital Campus
Apr 1, 2022